Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application
Relief Therapeutics Holding SA / Key word(s): Regulatory Approval21-Jun-2022 / 14:30 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Applicati...